TOUJEO DOUBLESTAR SOLUTION Canada - English - Health Canada

toujeo doublestar solution

sanofi-aventis canada inc - insulin glargine - solution - 300unit - insulin glargine 300unit - insulins

Toujeo SoloStar 300 unitsml solution for injection in a pre-filled pen Singapore - English - HSA (Health Sciences Authority)

toujeo solostar 300 unitsml solution for injection in a pre-filled pen

sanofi-aventis singapore pte. ltd. - insulin glargine - injection, solution - insulin glargine 300 units/ml

Toujeo 300 unitsml Solution for Injection in Pre-Filled Pen Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

toujeo 300 unitsml solution for injection in pre-filled pen

sanofi-aventis (malaysia) sdn. bhd. - insulin glargine -

TOUJEO- insulin glargine injection, solution United States - English - NLM (National Library of Medicine)

toujeo- insulin glargine injection, solution

a-s medication solutions - insulin glargine (unii: 2zm8cx04rz) (insulin glargine - unii:2zm8cx04rz) - insulin glargine 300 u in 1 ml - toujeo is indicated to improve glycemic control in adults and pediatric patients 6 years of age and older with diabetes mellitus. limitations of use: toujeo is not recommended for the treatment of diabetic ketoacidosis. toujeo is contraindicated: - during episodes of hypoglycemia [see warnings and precautions (5.3)] . - in patients with hypersensitivity to insulin glargine or any excipients in toujeo [see warnings and precautions (5.5)] . risk summary published studies with use of insulin glargine during pregnancy have not reported a clear association with insulin glargine and adverse developmental outcomes (see data) . there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see clinical considerations) . rats and rabbits were exposed to insulin glargine in animal reproduction studies during organogenesis, respectively 50 times and 10 times the human subcutaneous dose of 0.2 unit/kg/day. overall, the effects of insulin glargine did not generally differ from those obser

TOUJEO MAX- insulin glargine injection, solution United States - English - NLM (National Library of Medicine)

toujeo max- insulin glargine injection, solution

a-s medication solutions - insulin glargine (unii: 2zm8cx04rz) (insulin glargine - unii:2zm8cx04rz) - toujeo is indicated to improve glycemic control in adults and pediatric patients 6 years of age and older with diabetes mellitus. limitations of use: toujeo is not recommended for the treatment of diabetic ketoacidosis. toujeo is contraindicated: - during episodes of hypoglycemia [see warnings and precautions (5.3)] . - in patients with hypersensitivity to insulin glargine or any excipients in toujeo [see warnings and precautions (5.5)] . risk summary published studies with use of insulin glargine during pregnancy have not reported a clear association with insulin glargine and adverse developmental outcomes (see data) . there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see clinical considerations) . rats and rabbits were exposed to insulin glargine in animal reproduction studies during organogenesis, respectively 50 times and 10 times the human subcutaneous dose of 0.2 unit/kg/day. overall, the effects of insulin glargine did not generally differ from those obser

TOUJEO 300 UI/ml 3 plumes precarregades 1.5 ml Andorra - English - CedimCat (Centre d'Informació de Medicaments de Catalunya)

toujeo 300 ui/ml 3 plumes precarregades 1.5 ml

Toujeo 300 Units (equivalent to 10.91mg)/ mL Solution for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

toujeo 300 units (equivalent to 10.91mg)/ ml solution for injection (sc)

sanofi-aventis philippines, inc. - insulin glargine - solution for injection (sc) - 300 units (equivalent to 10.91mg)/ ml

Toujeo 300 Units (equivalent to 10.91 mg)/mL Powder For Oral Suspension Solution for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

toujeo 300 units (equivalent to 10.91 mg)/ml powder for oral suspension solution for injection (sc)

sanofi-aventis philippines, inc. - insulin glargine - powder for oral suspension solution for injection (sc) - 300 units (equivalent to 10.91 mg)/ml

TOUJEO SOLUCIÓN INYECTABLE EN PLUMA DOSIFICADORA SOLOSTAR Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

toujeo solución inyectable en pluma dosificadora solostar

sanofi-aventis deutschland gmbh - insulina glargina - insulina glargina....300 u

TOUJEO 300 IU/ml Solution for Injection in Pre-filled Pen Solution for injection in pre-filled pen Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

toujeo 300 iu/ml solution for injection in pre-filled pen solution for injection in pre-filled pen

sanofi-aventis, germany - insulin glargine - solution for injection in pre-filled pen - 300 iu/ml